Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease1
Open Access
- 19 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 96 (4) , 1259-1267
Abstract
Bovine respiratory disease (BRD) is the most common cause of morbidity and mortality in North American beef cattle. Mannheimia haemolytica (Mh) is the bacterial pathogen most often isolated from cattle with BRD and the prevalence of antimicrobial resistance (AMR) in this organism has increased in recent years. Antimicrobials are commonly used to prevent BRD in cattle at high-risk of developing BRD, however, recent work would suggest that this practice might be one factor contributing to the increased prevalence of AMR in Mh. We hypothesized that the administration of the short-acting fluoroquinolone, enrofloxacin, would be just as effective as the long-acting triamilide, tulathromycin, in preventing BRD but would be less likely to select for AMR Mh in stocker calves at high-risk of developing BRD. Three hundred forty-one stocker calves were enrolled in the study with 172 calves in 4 pens being randomly assigned to treatment with enrofloxacin and 169 calves in 4 pens randomly assigned to treatment with tulathromycin. Calves within each treatment group were allocated to one of 4 replicate pens based on the week of enrollment. Of calves receiving enrofloxacin, 33.7% required treatment for BRD at least once within 45 days after arrival, compared to 18.3% of calves receiving tulathromycin (P = 0.040). The percentages of calves that required more than one treatment for BRD within 45 days after arrival did not differ statistically for those receiving enrofloxacin compared to those receiving tulathromycin (10.5% and 4.7%, respectively; P = 0.107) Likewise, the percentages of calves that died during the 45 day follow-up period did not differ for those receiving enrofloxacin compared to those receiving tulathromycin (12.2% and 10.1%, respectively; P = 0.592). Mannheimia haemolytica was cultured from 11% of calves sampled at arrival, and from 50% of calves sampled at revaccination 14-17 days later. There was a significant effect of sampling time on the proportion of calves carrying multi-drug resistant (MDR) isolates, with calves having a higher prevalence of MDR isolates at revaccination than arrival (100% vs. 13%; P < 0.001). Future research evaluating the impact of MDR on response to antimicrobial therapy is necessary.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or TulathromycinPLOS ONE, 2016
- Mannheimia haemolytica in Feedlot Cattle: Prevalence of Recovery and Associations with Antimicrobial Use, Resistance, and Health OutcomesJournal of Veterinary Internal Medicine, 2015
- Comparison of tulathromycin and tilmicosin on the prevalence and severity of bovine respiratory disease in feedlot cattle in association with feedlot performance, carcass characteristics, and economic factorsJournal of Animal Science, 2014
- Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic TargetAntimicrobial Agents and Chemotherapy, 2012
- Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattleAmerican Journal of Veterinary Research, 2011
- Metaphylactic Antimicrobial Therapy for Bovine Respiratory Disease in Stocker and Feedlot CattleVeterinary Clinics of North America: Food Animal Practice, 2010
- Effects of on-arrival versus delayed clostridial or modified live respiratory vaccinations on health, performance, bovine viral diarrhea virus type I titers, and stress and immune measures of newly received beef calves1Journal of Animal Science, 2009
- Pharmacokinetics and Pharmacodynamics of AntimicrobialsClinical Infectious Diseases, 2007
- BOARD-INVITED REVIEW: Recent advances in management of highly stressed, newly received feedlot cattleJournal of Animal Science, 2007
- Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle.2005